+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Beta-Propiolactone Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141858
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Beta-Propiolactone is an essential chemical intermediate and sterilant, experiencing rising demand as evolving industrial processes and regulatory environments drive innovation. Its multifunctional properties make it a strategic material choice for sectors navigating heightened quality, purity, and sustainability requirements.

Market Snapshot: Beta-Propiolactone’s Strategic Role in Chemical and Sterilization Markets

The global Beta-Propiolactone market demonstrates steady expansion with consistent adoption across chemical synthesis, pharmaceutical intermediates, and advanced sterilization solutions. Senior decision-makers are monitoring the compound's integration in key supply chains as companies look to bolster resilience and capture emerging opportunities. The market’s trajectory is supported by regulatory advancements, technology enhancements, and diversified end-use adoption patterns.

Scope & Segmentation: Core Areas Defining Beta-Propiolactone Adoption

The report provides actionable insights across primary segments and value chain touchpoints relevant for procurement, operations, and strategic planning:

  • Applications: Includes chemical synthesis, pharmaceutical intermediates, and sterilization methods such as filtration, gas, and steam techniques.
  • Synthesis Focus: Highlights copolymerization and ring-opening polymerization processes fueling high-performance polymer production.
  • Pharmaceutical End-Uses: Covers analgesic and antibiotic intermediate types that support innovative drug development pipelines.
  • Grade Variations: Chemical, industrial, and laboratory grades meet specifications across manufacturing and research domains.
  • Purity Levels: Evaluates the role of high, standard, and technical purity in determining application suitability.
  • End Users: Biotechnology companies, pharmaceutical manufacturers, and research institutions drive differentiated demand dynamics.
  • Distribution Channels: Direct sales, distributor partnerships, and online sales platforms align with volume and fulfillment needs across buyer categories.
  • Regions: Explores growth forces and constraints in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with further granularity for countries such as the United States, China, Germany, and others.
  • Leading Suppliers: Analyzes competitive strategies of Thermo Fisher Scientific Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Shanghai Macklin Biochemical Co., Ltd., and additional market participants.

Key Takeaways for Senior Decision-Makers

  • Beta-Propiolactone is increasingly critical in both polymer synthesis and sterilization, fostering innovation in industry and healthcare environments.
  • Market growth is tied to improved production techniques, enhanced product purity, and compliance with evolving regulations, especially in the Americas and Asia-Pacific.
  • Technological innovation in ring-opening polymerization opens niche markets for tailored copolymers, expanding commercial and R&D possibilities.
  • Sustainability drives supplier collaborations, with a rising focus on bio-based feedstocks and circular chemical processes.
  • Procurement patterns are shifting: strategic alliances and vertical integration enable cost control and secure access to vital raw materials.
  • Differentiation through service models, quality management, and regulatory readiness is essential for capturing high-potential segments.

Tariff Impact: United States 2025 Tariff Regime and Global Supply Chain Shifts

The 2025 introduction of revised U.S. tariffs has compelled Beta-Propiolactone producers to accelerate domestic capacity, optimize sourcing, and diversify supplier partnerships. Tariff-induced cost dynamics are intensifying rivalry and prompting higher inventory buffers and risk management strategies throughout the value chain.

Methodology & Data Sources

This report integrates in-depth primary interviews with industry professionals, regulatory authorities, and procurement managers. Validated with secondary research from peer-reviewed literature, regulatory filings, and public disclosures, all findings are peer-reviewed and backed by expert panel feedback for robust, actionable insight.

Why This Report Matters for Leadership

  • Empowers organizations with targeted recommendations to navigate regulatory compliance, supply chain volatility, and supply reliability within critical industries.
  • Uncovers actionable growth areas by linking segmentation intelligence with regional and technological trends shaping procurement and product development strategies.

Conclusion

Beta-Propiolactone’s expanding role in industrial and healthcare applications underscores the need for agile strategy and continuous innovation. Decision-makers leveraging these insights will be prepared to adapt to complex, evolving market dynamics and secure long-term value.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory scrutiny intensifies as agencies tighten permissible limits for beta-propiolactone sterilant
5.2. Surging vaccine production drives increased beta-propiolactone demand in biopharma sterilization processes
5.3. Shift towards bio-based and continuous flow synthesis for greener beta-propiolactone manufacturing
5.4. Supply chain volatility prompts strategic sourcing and inventory optimization for beta-propiolactone suppliers
5.5. Collaborative R&D efforts target novel polymer crosslinking applications leveraging beta-propiolactone chemistry
5.6. Emerging markets in Asia-Pacific fuel regional expansion of beta-propiolactone distribution networks and logistics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Beta-Propiolactone Market, by Application
8.1. Introduction
8.2. Chemical Synthesis
8.2.1. Synthesis Type
8.2.1.1. Copolymerization
8.2.1.2. Ring Opening Polymerization
8.3. Pharmaceutical Intermediate
8.3.1. Intermediate Type
8.3.1.1. Analgesic Intermediate
8.3.1.2. Antibiotic Intermediate
8.4. Sterilization
8.4.1. Sterilization Method
8.4.1.1. Filtration Sterilization
8.4.1.2. Gas Sterilization
8.4.1.3. Steam Sterilization
9. Beta-Propiolactone Market, by Grade
9.1. Introduction
9.2. Chemical Grade
9.3. Industrial Grade
9.4. Laboratory Grade
10. Beta-Propiolactone Market, by Purity
10.1. Introduction
10.2. High Purity
10.3. Standard Purity
10.4. Technical Purity
11. Beta-Propiolactone Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.3. Pharmaceutical Industry
11.4. Research Institutions
12. Beta-Propiolactone Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Sales
13. Americas Beta-Propiolactone Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Beta-Propiolactone Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Beta-Propiolactone Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Tokyo Chemical Industry Co., Ltd.
16.3.4. Shanghai Macklin Biochemical Co., Ltd.
16.3.5. Aladdin Industrial Corporation
16.3.6. Spectrum Chemical Mfg. Corp.
16.3.7. ABCR GmbH & Co. KG
16.3.8. Sisco Research Laboratories Pvt. Ltd.
16.3.9. Santa Cruz Biotechnology, Inc.
16.3.10. Heowns Biochem Co., Ltd.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. BETA-PROPIOLACTONE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BETA-PROPIOLACTONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BETA-PROPIOLACTONE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BETA-PROPIOLACTONE MARKET: RESEARCHAI
FIGURE 26. BETA-PROPIOLACTONE MARKET: RESEARCHSTATISTICS
FIGURE 27. BETA-PROPIOLACTONE MARKET: RESEARCHCONTACTS
FIGURE 28. BETA-PROPIOLACTONE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BETA-PROPIOLACTONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY COPOLYMERIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY COPOLYMERIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY RING OPENING POLYMERIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY RING OPENING POLYMERIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ANALGESIC INTERMEDIATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ANALGESIC INTERMEDIATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ANTIBIOTIC INTERMEDIATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ANTIBIOTIC INTERMEDIATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GAS STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GAS STERILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY LABORATORY GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY LABORATORY GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY HIGH PURITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY HIGH PURITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STANDARD PURITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY STANDARD PURITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY TECHNICAL PURITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY TECHNICAL PURITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BETA-PROPIOLACTONE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BETA-PROPIOLACTONE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 132. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 133. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 136. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 142. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 143. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 144. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 145. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 146. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 147. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BETA-PROPIOLACTONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 272. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 273. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 274. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 275. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 276. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 277. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 280. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 290. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 291. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 292. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 293. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 294. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 295. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 296. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 297. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 298. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 299. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 302. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY INTERMEDIATE TYPE, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY GRADE, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY PURITY, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA BETA-PROPIOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 332. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 333. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2018-2024 (USD MILLION)
TABLE 334. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY SYNTHESIS TYPE, 2025-2030 (USD MILLION)
TABLE 335. ITALY BETA-PROPIOLACTONE MARKET SIZE, BY PHARMACEUTICAL INTERMEDIATE, 2018-2024 (USD MILLION)
TABLE 336. ITALY B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Beta-Propiolactone Market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Tokyo Chemical Industry Co., Ltd.
  • Shanghai Macklin Biochemical Co., Ltd.
  • Aladdin Industrial Corporation
  • Spectrum Chemical Mfg. Corp.
  • ABCR GmbH & Co. KG
  • Sisco Research Laboratories Pvt. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • Heowns Biochem Co., Ltd.